-PTI The government today approved road projects worth Rs 4,620 crore in Assam and Madhya Pradesh for the widening of National Highways. All the four projects, including three in Assam for widening of stretches of National Highways 37 under Special Accelerated Road Development Programme in North Eastern Region (SARDP-NE) at a cost of Rs 1,933 crore, were approved by the Cabinet Committee on Economic Affairs (CCEA). "The CCEA has given its approval for...
More »SEARCH RESULT
Alphabetical order to discrimination-Sanjay Srivastava
-The Hindu Considering the knowledge of English as a mark of social advancement and that of the vernacular as backwardness disenfranchises significant sections of society In a village in Ghazipur district that borders Varanasi, there is a young man who teaches English and "personality Development" to the sons and daughters of local shopkeepers, farmers and truck drivers. The classes are held from 6 to 8 in the morning and again in the...
More »Artful claims can’t decide patent law: court-J Venkatesan
-The Hindu The law of patent in India could not be developed on the artful drafting of claims by companies rather than on the intrinsic worth of invention, the Supreme Court has ruled, rejecting Novartis' claim for patent for its cancer drug. A Bench of Justices Aftab Alam and Ranjana Desai said, "We certainly do not wish the law of patent... to develop on the lines where there may be a vast...
More »Poll panel moves court to reject panchayat schedule
-PTI Kolkata: The Election Commission in West Bengal today moved the Calcutta Hight Court seeking rejection of the government notification on poll schedule as the state government decided to contest it. The State Election Commission in its petition claimed that Section 42 of the West Bengal Panchayat Election Act, which states that the state government is empowered to notify election in consultation with the commission, is unconstitutional. The commission also prayed that it...
More »Domestic pharma lauds apex court verdict-Reghu Balakrishnan
-The Business Standard Patients' lobbies cheer ruling on anti-cancer drug Glivec, as affordability and access to life-saving drugs get a leg-up Though the India office here of Swiss pharma giant Novartis wore a gloomy look following the Supreme Court rejection of its Glivec patent application, Indian pharmaceutical companies and patients' associations are in celebration mood. D G Shah, secretary general, The Indian Pharmaceutical Alliance (IPA), comprising leading research-based Indian pharma companies, said,...
More »